US equities |
MU $1,088.00 ▲+4.06% NVDA $237.47 ▼-0.74% SNDK $1,692.42 ▲+1.92% SPCX $167.60 ▼-2.51% AMD $645.86 ▼-0.55% AAPL $336.67 ▲+0.91% TSLA $377.81 ▼-0.75% INTC $113.12 ▲+0.55%
FinancialContent

Latest News about CMAX Clinical Research

Recent news which mentions CMAX Clinical Research

Incannex Approved For Bioavailability Clinical Trial For Dronabinol-Based Drug For Treatment Of Obstructive Sleep Apnea
Tickers IXHL
Tags premium CMAX Clinical Research Novotech
From Benzinga
Nasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For Epilepsy
Tickers DRUG
Tags Dr/ Revati Shreeniwas Cannabis DRUG
From Benzinga
Incannex Approved To Commence Phase 1 Clinical Trial Of CBD Based Anti-Inflammatory Drug
Tickers IXHL
Tags Dr Mark Bleackley Cannabis News
From Benzinga